FDA Calls Off Closed Hearing On Blood Substitute

Law360, New York (July 14, 2006, 12:00 AM EDT) -- Cowed by a consumer group lawsuit to open a closed-door meeting, the Food and Drug Administration decided to postpone Friday’s hearing to discuss the U.S. Navy’s proposition to proceed with a blood substitute trial.

The FDA said Thursday that the advisory panel meeting would be switched to an open meeting at a later date after consumer group Public Citizen’s Health Research Group filed a lawsuit Wednesday in the U.S. District Court for the District of Columbia demanding the agency either cancel the meeting or open it...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.